Previous studies have reported that TPF regimen is effective in the treatment of nasopharyngeal carcinoma, but the side effects related to fluorouracil, a chemotherapeutic drug, limit the clinical application of this regimen. Therefore, we try to compare the progression-free survival time and side effects of TP and TPF as induction chemotherapy combined with concurrent radiotherapy and chemotherapy for stage ⅲ-ⅳ A nasopharyngeal carcinoma (excluding T3-4N0) through prospective, randomized controlled, multicenter clinical studies, in order to confirm that TP has similar curative effect and less side effects than TPF, and provide a more optimized treatment scheme for patients with advanced nasopharyngeal carcinoma.
正在翻译中..